FibroGen (FGEN) Tops Q3 EPS by 21c

FibroGen (NASDAQ: FGEN) reported Q3 EPS of ($0.38), $0.21 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $30.1 million versus the consensus estimate of $24.3 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• L3Harris Technologies (LHX) Tops Q1 EPS by 15c; raises guidance
• Universal Logistics Holdings, Inc. (ULH) Tops Q1 EPS by 136c